Europe and Japan Allergy Immunotherapy Market

1. Europe and Japan Allergy Immunotherapy Market Analysis On The Basis Of Current Industry Demand, Growth Rate, New Trends and Key Players Immunotherapy is a preventive treatment for allergic reactions which are caused by substances such as grass pollens, house dust mites and bee venom. While providing immunotherapy treatment to patients, the dose of the drug is gradually increased to which the person is allergic. Immunotherapy also reduces the inflammation that characterizes rhinitis and asthma. Allergy shots, also known as subcutaneous immunotherapy (SCIT), is the most commonly used immunotherapy and this is the only treatment available that actually changes the immune system, making it possible to prevent development of new allergies and asthma. Market Dynamics: Market players are involved in research and development activities for development of drugs for allergy immunotherapy and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in May 2018, Stallergenes Greer, a biopharmaceutical company, announced positive results for its phase III clinical trial which was carried out, in order to evaluate the efficacy and safety of its sublingual allergy immunotherapy tablet STAGR320, for the treatment of house dust mite. Key players are engaged in receiving approvals for their drugs, from the regulatory authorities and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in November 2018, Stallergenes Greer, a biopharmaceutical company, received approval from the U.S. Food and Drug Administration (US FDA), for the extension of the indication for Oralair, for the treatment of patients with grass pollen-induced allergic rhinitis. Moreover, in September 2018, Torii Pharmaceutical Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare had approved the New Drug Application (NDA) for the Japanese cedar sublingual allergy immunotherapy (SLIT) tablet, i.e, CEDARCURE. To know the latest trends and insights prevalent in the Global Europe and Japan Allergy Immunotherapy Market, click the link below: Sample PDF: - https://www.coherentmarketinsights.com/insight/request-pdf/5037 Key features of the study: This report provides an in-depth analysis of the Europe and Japan allergy immunotherapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022- 2030), considering 2021 as the base year

2. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players It profiles leading players in the Europe and Japan allergy immunotherapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distri- bution strategies, key developments and strategies, and future plans Key companies covered as a part of this study include Novartis International AG, Merck & Co., Inc., Aim- mune Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., HAL Allergy B.V., Stallergenes Greer, ALK-Abelló A/S, Allergy Therapeutics Plc, Torii Pharmaceutical Co., Ltd., DESENTUM OY Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics The Europe and Japan allergy immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts Stakeholders would have ease in decision-making through various strategy matrices used in analysing the Europe and Japanallergy immunotherapy market. Detailed Segmentation: Europe and Japan Allergy Immunotherapy Market, By Treatment: oSubcutaneous Immunotherapy (SCIT) oSublingual Immunotherapy (SLIT) Europe and Japan Allergy Immunotherapy Market, By Allergy Type: oAllergy Rhinitis oAllergy Asthma oPollen Allergies Cedar Birch Oak Others oPet Allergy

3. Cats Dogs Other Pets oBirds Allergy oOthers Europe and Japan Allergy Immunotherapy Market, By Distribution Channel: oHospital Pharmacies oRetail Pharmacies oOnline Pharmacies Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/5037 Table of Contents 1.Research Objectives and Assumptions oResearch Objectives oAssumptions oAbbreviations 2.Market Overview oReport Description Market Definition and Scope oExecutive Summary Market Snippet, By Treatment Market Snippet, By Allergy Type Market Snippet, By Distribution Channel Market Snippet, By Region oCoherent Opportunity Map (COM) 3.Market Dynamics, Regulations, and Trends Analysis oMarket Dynamics Drivers Restraints Market Opportunities

4. oImpact Analysis oRegulatory Scenario oPEST Analysis oRecent Product Launch/Approval oEpidemiology oMergers and Acquisitions 4.Europe and Japan Allergy Immunotherapy Market - Impact of Coronavirus (Covid-19) Pandemic oImpact on Supply Chain oImpact on Research and Development oGovernment Initiatives 5.Europe and Japan Allergy Immunotherapy Market, By Treatment, 2017-2030 (US$ Million) oIntroduction Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2018 - 2030 Segment Trends oSubcutaneous Immunotherapy (SCIT) Introduction Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million) oSublingual Immunotherapy (SLIT) Introduction Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million) To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/5037 About US: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defence, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

5. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: sales@coherentmarketinsights.com